Location: San Diego, CA
CIK: 0001232621 · Show all filings
Period: Q3 2015 (← Previous) (Next →)
Filing Date: Nov 16, 2015
Total Value: $271M (91.3% shares, 8.7% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| HRTX | HERON THERAPEUTICS INC | 5,190,837 | $127M | 46.7% | $12.86 | +159.1% | COM | 427746102 |
| — | LA JOLLA PHARMACEUTICAL CO | 2,914,970 | $81.01M | 29.9% | $14.41 | — | COM | 503459604 |
| OPK | OPKO HEALTH INC | 2,475,000 | $20.82M | 7.7% | $13.24 | 0.0% | COM | 68375N103 |
| BMRN | BIOMARIN PHARMACEUTICAL INC | 182,300 | $19.2M | 7.1% | $62.32 | +114.3% | COM | 09061G101 |
| — | OPKO HEALTH INC | 14,000,000 | $18.25M | 6.7% | $1.47 | — | DEBT 3.0% 2/1/33 | 68375NAB9 |
| — | MERRIMACK PHARMACEUTICALS INC | 3,500,000 | $5.259M | 1.9% | $1.36 | — | NOTE 4.5% 7/15/20 | 590328AA8 |